Join to View Full Profile
50 Staniford StBoston, MA 02114
Phone+1 617-643-8618
Dr. Reddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Dermatology, 2013 - 2016
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2013
Rutgers New Jersey Medical SchoolClass of 2012
Certifications & Licensure
MA State Medical License 2016 - 2026
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 11 citationsLoss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF Inhibition.Zhenyu Ji, Ching-Ni Njauw, Samantha M. Guhan, Raj Kumar, Bobby Y. Reddy
The Journal of Investigative Dermatology. 2021-05-01 - 10 citationsSurgical Delay and Mortality for Primary Cutaneous Melanoma.Samantha M. Guhan, Genevieve M. Boland, Kenneth K. Tanabe, William M. Lin, Bobby Y. Reddy
Journal of the American Academy of Dermatology. 2021-04-01 - 10 citationsGrowth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.Raj Kumar, Ching-Ni Njauw, Bobby Y. Reddy, Zhenyu Ji, Anpuchchelvi Rajadurai
Oncogene. 2019-01-16
Press Mentions
From Razor Burn to Bacne: Your Biggest Summer Skin Problems, SolvedJuly 12th, 2021
How to Make Heat Rash, Razor Burn and Bacne DisappearJuly 24th, 2018
NantHealth to Present and Exhibit on the Convergence of Precision Medicine and Value-Based Care at America’s Health Insurance Plans (AHIP) Institute & Expo 2018June 19th, 2018- Join now to see all
Grant Support
- Clinical Validation of a Point-of-Care Precision Medicine Endotyping PlatformPRENOSIS, INC.2024–2026
- Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response MapPRENOSIS, INC.2023–2025
- Combined Biomarker and EMR Data for Heterogeneous Treatment Effects and Surrogate Endpoints in SepsisPRENOSIS, INC.2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
